Enveda's $311M Funding: Boosting AI-Driven Drug Development
Enveda Biosciences has raised $311 million to drive AI-based drug development, focusing on nature-derived treatments for skin issues and weight management.
Latest news and articles
1 article published
Enveda Biosciences has raised $311 million to drive AI-based drug development, focusing on nature-derived treatments for skin issues and weight management.